
    
      Patients undergo one standard apheresis to harvest peripheral mononuclear cells for dendritic
      cell vaccine preparation. The modified cells (vaccine) are frozen so that multiple injections
      may be given. Patients my receive up to 5 injections. The vaccine is given either
      intradermally or into a lymph node.

      Patients will undergo blood sample collection for immune response studies on the day of
      treatment and 2 weeks following treatment.
    
  